A revolutionary vaccine can double the survival rate of patients with one of the most aggressive forms of brain cancer.

A study led by a team at King's College Hospital found the treatment can extend survival for many months and in some cases years.

And for some people with brain cancer, its approval for use in the UK cannot come sooner, as John Ray reports.

• Subscribe to ITV News on YouTube: [ Ссылка ]
• Get breaking news and more stories at [ Ссылка ]

Follow ITV News on Facebook: [ Ссылка ]
Follow ITV News on Twitter: [ Ссылка ]
Follow ITV News on Instagram: [ Ссылка ]

свернуть